-
-
-
-
-
-
-
Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance
-
-
-
-
-
-
-
Elevance (ELV) PT Raised to $424 at Bernstein SocGen
-
-
-
-
-
-
-
Evercore ISI Starts Elevance (ELV) at In Line
-
-
-
-
-
-
-
Elevance Health flags earnings decline amid bleak Medicare Advantage proposal
-
-
-
-
-
-
-
Elevra Lithium December 2025 Quarterly Report Advisory and Change of Presentation Currency
-
-
-
-
-
-
-
Elevance (ELV) PT Lowered to $400 at Mizuho
-
-
-
-
-
-
-
Elevance Health earnings preview: Wolfe sees conservative 2026 guidance as potential ‘bottom’
-
1,218,575 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

